Journal of Clinical Endocrinology & Metabolism, Vol 76, 988-995, Copyright © 1993 by Endocrine Society

ARTICLES

Administration of an aromatase inhibitor during the late follicular phase of gonadotropin-treated cycles in rhesus monkeys: effects on follicle development, oocyte maturation, and subsequent luteal function

MB Zelinski-Wooten, DL Hess, WL Baughman, TA Molskness, DP Wolf and RL Stouffer
Division of Reproductive Sciences, Oregon Regional Primate Research Center, Beaverton 97006.

Local modulation of follicular and gametogenic functions by ovarian androgens and estrogens in mammalian species has been proposed. This study examined the effects of elevated androgen/estrogen ratios during follicular maturation in vivo by inhibiting aromatase activity in rhesus monkeys. To obviate steroid feedback effects, gonadotropin- treated animals were used. Beginning at menses (day 1), animals received human (h) FSH (60 IU/day, im) on days 1-6, followed by hFSH plus hLH (60 IU/day, im) on days 7-9 to promote the growth of multiple follicles. Ovulatory maturation was induced by hCG (1000 IU, im) on day 10. On days 8-10, four animals received an aromatase inhibitor, 1,4,6- androstatrien-3,17-dione (ATD; 1-1.25 g, orally, twice/day), while five served as controls and received no further treatment. Within 8 h of ATD treatment, a 63% reduction in serum estradiol levels relative to control values was evident, which reached maximal suppression (84%) by day 10. A marked elevation (17-fold) in serum androstenedione and a lesser increase (2.6-fold) in serum testosterone occurred with aromatase inhibition, yielding androstenedione/estradiol (18.0) and testosterone/estradiol (1.9) ratios greater than those in controls (0.6 and 0.3, respectively). ATD treatment did not alter follicular diameters or the total number of follicles per animal (20 +/- 3) relative to control values (16 +/- 3). Of the total cohort classified, the proportion of oocytes collected at prophase I was greater (P < 0.05) after ATD treatment (31%) than in controls (11%). Completion of oocyte meiosis to metaphase II was retarded (P < 0.05) in ATD-treated (4%) compared to control (26%) animals. Furthermore, the in vitro fertilization rate of metaphase II oocytes from ATD-treated animals (9%) was reduced (P < 0.05) relative to that in controls (25%). While basal progesterone production by luteinizing granulosa cells in vitro was similar between groups, the addition of hCG in vitro enhanced progesterone secretion by cells from ATD-treated animals (3.1 +/- 0.3- fold over basal) to a greater extent (P = 0.05) than in controls (1.5 +/- 0.3-fold). Progesterone receptor was detected by immunocytochemistry in nuclei of luteinizing granulosa cells from ATD- treated animals as well as controls. Serum progesterone profiles and the length of the luteal phase were similar between groups. Thus, acute elevation of serum androgen/estrogen ratios in vivo during follicular maturation was detrimental to the gametogenic functions of the primate follicle, but did not alter follicular growth, events of early luteinization, or subsequent luteal function.(ABSTRACT TRUNCATED AT 400 WORDS)

This article has been cited by other articles:

				S. Motola, M. Popliker, and A. Tsafriri Are Steroids Obligatory Mediators of Luteinizing Hormone/Human Chorionic Gonadotropin-Triggered Resumption of Meiosis in Mammals? Endocrinology, September 1, 2007; 148(9): 4458 - 4465. [Abstract] [Full Text] [PDF]

				S. M. Borman, C. L. Chaffin, K. M. Schwinof, R. L. Stouffer, and M. B. Zelinski-Wooten Progesterone Promotes Oocyte Maturation, but Not Ovulation, in Nonhuman Primate Follicles Without a Gonadotropin Surge Biol Reprod, July 1, 2004; 71(1): 366 - 373. [Abstract] [Full Text] [PDF]

				A. J. Zeleznik, L. Little-Ihrig, and S. Ramasawamy Administration of Dihydrotestosterone to Rhesus Monkeys Inhibits Gonadotropin-Stimulated Ovarian Steroidogenesis J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 860 - 866. [Abstract] [Full Text] [PDF]

				P. Zheng, W. Si, B. D. Bavister, J. Yang, C. Ding, and W. Ji 17{beta}-Estradiol and progesterone improve in-vitro cytoplasmic maturation of oocytes from unstimulated prepubertal and adult rhesus monkeys Hum. Reprod., October 1, 2003; 18(10): 2137 - 2144. [Abstract] [Full Text] [PDF]

				C. Taupeau, J. Poupon, D. Treton, A. Brosse, Y. Richard, and V. Machelon Lead Reduces Messenger RNA and Protein Levels of Cytochrome P450 Aromatase and Estrogen Receptor {beta} in Human Ovarian Granulosa Cells Biol Reprod, June 1, 2003; 68(6): 1982 - 1988. [Abstract] [Full Text] [PDF]

				D. A. Dumesic, R. D. Schramm, E. Peterson, A. M. Paprocki, R. Zhou, and D. H. Abbott Impaired Developmental Competence of Oocytes in Adult Prenatally Androgenized Female Rhesus Monkeys Undergoing Gonadotropin Stimulation for in Vitro Fertilization J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1111 - 1119. [Abstract] [Full Text] [PDF]

				S. F. Palter, A. B. Tavares, A. Hourvitz, J. D. Veldhuis, and E. Y. Adashi Are Estrogens of Import to Primate/Human Ovarian Folliculogenesis? Endocr. Rev., June 1, 2001; 22(3): 389 - 424. [Abstract] [Full Text] [PDF]

				D. P. Levy, J. M. Navarro, G. L. Schattman, O. K. Davis, and Z. Rosenwaks The role of LH in ovarian stimulation: Exogenous LH: let's design the future Hum. Reprod., November 1, 2000; 15(11): 2258 - 2265. [Abstract] [Full Text] [PDF]

				C. L. Chaffin, R. L. Stouffer, and D. M. Duffy Gonadotropin and Steroid Regulation of Steroid Receptor and Aryl Hydrocarbon Receptor Messenger Ribonucleic Acid in Macaque Granulosa Cells during the Periovulatory Interval Endocrinology, October 1, 1999; 140(10): 4753 - 4760. [Abstract] [Full Text]

				R.D. Schramm and B.D. Bavister A macaque model for studying mechanisms controlling oocyte development and maturation in human and non-human primates Hum. Reprod., October 1, 1999; 14(10): 2544 - 2555. [Abstract] [Full Text] [PDF]

				J. A. McCracken, E. E. Custer, and J. C. Lamsa Luteolysis: A Neuroendocrine-Mediated Event Physiol Rev, April 1, 1999; 79(2): 263 - 323. [Abstract] [Full Text] [PDF]

				B. C. J. M. Fauser and A. M. van Heusden Manipulation of Human Ovarian Function: Physiological Concepts and Clinical Consequences Endocr. Rev., February 1, 1997; 18(1): 71 - 106. [Abstract] [Full Text]